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Abstract
Salmonids are one of the world’s most farmed fish species. These aquatic vertebrate
species rely heavily on their innate immune responses to defend themselves against invading
pathogens. Although commercial vaccines are available against some viral and bacterial pathogens
affecting salmonids, their protective efficacy is variable. Using a prophylactic inducer of local and
systemic innate immune responses could have significant implications in salmonid aquaculture. A
potent inducer of the innate immune response in fish is double-stranded RNA (dsRNA), a molecule
that all viruses make during their replicative cycle. Polyinosinic:polycytidylic acid (polyI:C) is a
synthetic dsRNA commonly used to induce type I interferons (IFNs), interferon stimulated genes
(ISGs) as well as an antiviral state in vertebrate species. Recent research has shown that by
complexing it with a phytoglycogen nanoparticle, it can increase the efficacy of polyI:C and induce
enhanced innate immune responses. Since this nanoparticle is naturally derived from sweet corn,
it is biodegradable and non-toxic making it ideal for both in vivo and in vitro work. The
nanoparticle was complexed with polyI:C to stimulate enhanced innate immune responses in
rainbow trout and Atlantic salmon, as well as to prevent viral replication in Atlantic salmon
infected with infectious salmon anaemia virus (ISAV). This complex was tested as both an oral
gavage and incorporated into commercially available feed pellets to test both controlled dose
delivery (oral gavage) and standard feeding delivery (feed pellets). The polyI:C-nanoparticles
(polyI:C-NanodendrixTM; NDx) complex was effective in initiating key innate immune
components such as IFN and ISGs and its induced response was greater than polyI:C alone or NDx
alone. This was found to be the case both locally, in the intestine, and systemically, in the head
kidney. The novel feed pellets were also able to prevent viral replication in the intestine of Atlantic
salmon that were infected with ISAV via co-habitation. This research may lead to a novel approach
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for drug delivery, leading to the prevention of pathogen infections and healthier farmed fish
species.
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Chapter 1. Literature Review
1.1 Innate Immunity
The immune response of all vertebrate species is a reaction against foreign invaders to prevent
infection. This response can be broken down into two main components: the innate immune
response and the adaptive immune response. The adaptive immune response is classified as antigen
specific responses which create an immunological memory for future infections whereas the innate
immune response is a non-specific response initiated immediately following infection of a
pathogen (Stewart, 2012). The innate immune response is of particular importance for fish species
as they tend to have weaker adaptive immune systems and rely heavily on their non-specific innate
immune responses (Uribe et al., 2011). Innate immunity is composed of constitutive and induced
responses. Constitutive responses include both chemical and physical barriers. The induced
response relies heavily on germ-line encoded pattern recognition receptors (PRRs), that recognize
and bind pathogen associated molecular patterns (PAMPs) to destroy and clear pathogens by
inducing type I interferons (IFNs) and interferon stimulated genes (ISGs) which create an antiviral
state within the host organism.

1.1.1 Fish Innate Immunity
The first line of defense against invading pathogens in fish species are physical barriers that
protect them against their external environment (Collet, 2014). These physical barriers range from
the skin, including scales and mucus, gills, and the gut, to block pathogens from entering the fish.
These physical barriers can be coated in mucus which contains important immune factors such as
lectins, lysozymes, antibacterial peptides, immunoglobulin (IgM) and complement proteins that
work together to identify and break down pathogens (Saurabh and Sahoo, 2008). If these barriers
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begin to fail, harmful microbes may enter at sites most vulnerable to infection such as the base of
fins where mucus layers begin to thin due to continual rapid movement (Harmache et al., 2006).
Once pathogens begin to overcome physical barriers, induced innate immune responses such as
inflammation are activated and are a crucial part of innate immunity (Hussell and Goulding, 2010).
The activation of cytokines, such as IL-1β, TNF-α, chemokines and chemotactic migration of
leukocytes, such as macrophages and neutrophils, all work to create an inflammatory response to
prevent the spread of pathogens in salmonid fish species (Collet, 2014). This inflammatory
response is induced when fish PRRs recognize PAMPs.
There are a multitude of PRRs in fish dedicated to recognising PAMPs to prevent infection.
For virus infections, nucleic acid sensing PRRs play key roles in the innate antiviral immune
response. For example, toll-like receptor 3 (TLR3) is located in the membrane of the endosome to
recognize and bind double stranded RNA (dsRNA), the genetic material or replicative by-product
of viruses (Collet, 2014). TLR3 binding to dsRNA requires the low pH environment of an acidified
endosome (Leonard et al., 2008). TLR7/TLR8 and TLR9 are also important PRRs as they
recognize and bind single stranded RNA (ssRNA) and dsDNA respectively, produced by viruses
in both mammals and fish (Palti et al., 2010; Ortega-Villaizan et al., 2009). Cytoplasmic nucleic
acid PRRs are also essential for fish innate antiviral immunity. These include retinoic acidinducible gene I (RIG-I) and melanoma-differentiation-associated gene 5 (MDA5) which are
cytoplasmic helicases that also recognize dsRNA (Ortega-Villaizan et al., 2009). Signaling
downstream from these TLRs and RLRs can result in induction of inflammatory and type I IFN
responses.

15

1.2 Double Stranded RNA
A common inducer of innate immune responses in vertebrate species is dsRNA. DsRNA is a
molecule that most viruses produce during some point of their replicative cycle (Doherty et al.,
2016). For example, single stranded (ss)RNA viruses make dsRNA from their replicative
intermediates whereas the genome is the source of dsRNA in dsRNA viruses. DsDNA viruses also
produce dsRNA during their replicative cycle using bidirectional convergent transcription; when
complementary mRNAs are produced and anneal together to form long strands of dsRNA
(DeWitte-Orr and Mossman, 2010). The structure of dsRNA consists of a right-handed double
helix of two antiparallel strands (DeWitte-Orr and Mossman, 2010), which was determined using
fiber diffraction, x-ray diffraction and high-resolution nuclear magnetic resonance analyses
(Nicholson, 2006). This molecule exhibits as an α-helix motif containing an 11-fold helical pitch
with a narrow and deep major groove and a shallow minor groove (DeWitte-Orr and Mossman,
2010). The minor groove contains 2’-hydroxyl groups which is the interactive surface for binding
proteins and other nucleic acids. (DeWitte-Orr and Mossman, 2010). Although viral dsRNA is a
potent inducer of innate immune responses, it is hard to collect in useful quantities for research,
leading to the development of a synthetic form of viral dsRNA, polyI:C, in the late 1960s.

DsRNA is sensed both extracellularly and intracellularly through a wide variety of receptors.
Every nucleated cell in higher vertebrates has the potential to detect viruses via cytoplasmic and
membrane-bound receptors (Collet, 2014). Extracellular dsRNA is first sensed at the cell surface
by class A scavenger receptors (SR-A) or toll-like receptor (TLR)22. Using clathrin-mediated
endocytosis the dsRNA is carried to endoplasmic TLR3 (DeWitte-Orr et al, 2010). TLR3 then
recognizes and binds the dsRNA to activate TRI-domain-containing adaptor protein IFN-β (TRIF)

16

also known as TICAM-1 (Figure 1. a). Activated TRIF activates kinases that phosphorylate IFN
regulator factor (IRF)3 and IRF7, which when phosphorylated translocate from the cytoplasm to
the nucleus. Inside the nucleus IRF3 and IRF7 bind to the IFN gene promoter to trigger
transcription of IFNs (Sun et al, 2010), an important innate immune cytokine.

DsRNA can also escape the endosome and be sensed by a group RIG-I-like receptors (RLRs)
located in the cytoplasm (Figure 1. b). This group of receptors consists of RIG-I, MDA5 and
laboratory of genetics physiology 2 (LGP2). Cytoplasmic dsRNA binds to either RIG-I or MDA5
and then associates with IFN-β promoter stimulator-1 (IPS-1). IPS-1 activation leads to the
phosphorylation of IRF3 and IRF7 and the initiation of IFN transcription to fight viral infections.
It has been shown in mammals that dsRNA recognition by RLRs is length dependent, where RIGI detects dsRNA 300-1000bp in length and MDA5 detects dsRNA longer than 1000bp in length
(Kato et al, 2008). DsRNA may also be recognized in the cytoplasm by another PRR known as
protein kinase R (PKR). PKR is a dsRNA dependent protein kinase that is constitutively present
and IFN-inducible (Poytner and DeWitte-Orr, 2016). Once PKR binds dsRNA, dimerization
occurs, autophosphorylation takes place, and PKR becomes active (Poynter and DeWitte-Orr,
2016). PKR will either phosphorylate Iκβ to release NF-κβ which translocates to the nucleus to
induce IFN-β, or it will phosphorylate the eukaryotic-translation initiation factor 2α (eIF2α) which
then stops viral protein translation (Kumar et al., 1997).
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a)

b)

Figure 1. a) Schematic showing dsRNA pathway to signal IFN production in aquatic vertebrates.
DsRNA is recognized on the cells surface by SR-A or TLR22 or by TLR3 present in the endosome.
Binding of dsRNA activates TRIF, which activates kinases (TBK1). These kinases phosphorylate
IRF3/7 which stimulates transcription of IFN in the nucleus. b) DsRNA that escapes the endosome
is recognized by either RIG-I or MDA5 and then uses MAVS (IPS-1) leading to the induction of
IRF3/7 to initiate transcription of IFN. Figure produced in Biorender and adapted from Zhang and
Gui, 2012.

1.2.1 Commercially available dsRNA: PolyI:C
A common synthetic mimic of viral dsRNA used in laboratory settings to stimulate viral
infections is polyinosinic:polycytidylic acid (polyI:C). This synthetic molecule is a mismatched
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dsRNA consisting of two strands, one a polymer of inosinic acid and one a polymer of cytidylic
acid containing the same ribose-phosphate backbone of an RNA molecule (Davies and Rich,
1958). Since it is a synthetic mimic of viral dsRNA, it is recognized in the same way by SRs and
TLR3 to induce production of IFN as previously described. Since its discovery in the late 1960s,
polyI:C has been used in place of viral dsRNA as a TLR3 agonist to study its effects on innate
immune responses. It is available as both high and low molecular weight (HMW and LMW)
ranging from 1.5-8kb and 0.2-1kb respectively. Although it is a strong innate inducer and initially
thought to be an antiviral therapeutic, it was soon found to be toxic in mammals (DeWitte-Orr and
Mossman, 2010). PolyI:C is considered a strong inducer of innate responses in vitro; however, it
does not perform as effectively in vivo due to a lack of natural structures, base compositions, and
sequence variations (Poynter and DeWitte-Orr, 2015). For this reason, it may be beneficial to use
delivery systems such as phytoglycogen nanoparticles (PhG NPs) (discussed in section 4.1), to
increase polyI:C’s efficacy as an antiviral therapeutic in vivo.
Although the use of polyI:C as innate immune stimulate in teleost fish is not new, there are
currently no studies that test its effects when delivered orally. This immunostimulant has mainly
been delivered through IP injection in both trout and salmon (Jensen et al., 2002; Lockhart et al.,
2004; Lulijwa et al., 2020). PolyI:C when delivered through IP injection has been shown to
effectively stimulate IFN as well as many different ISGs including Mx proteins and Vig3
(Trobridge et al., 1997; Jensen et al., 2002; Lockhart et al., 2004; Nishizawa et al., 2009) however
this method of stimulation requires intensive handling of the fish. Handling of fish may induce
stress responses such as increased production of the corticosteroid cortisol that suppresses immune
responses (Turner et al., 2011). A reduction in immune responses can make fish more susceptible
to pathogenic infections. The addition of the immunostimulant to fish feed would eliminate the
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added handling of fish associated with IP injections and may be a more feasible option for fish
farmers globally. It has been suggested that antigens when delivered orally are highly susceptible
to degradation due to the acidic environment of the stomach and GI tract, however complexing it
with a nanocarrier may help prevent this. For these reasons polyI:C delivered orally may prove to
be a more effective method to deliver immunostimulants in the aquaculture industry for fish
farmers.

1.3 Type I Interferons
Type I IFNs are a diverse group of signaling molecules that induce innate and adaptive immune
responses following viral or bacterial infections (Boxx and Cheng, 2016). IFNs are cytokines
whose expression is induced by pathogens to ‘interfere’ with their ability to successfully replicate
within a host. IFNs were first identified in the late 1950s in chick choriallantoic membranes and
have since been identified in a multitude of different vertebrate species including fish (Pestka,
2007). To date there have been three classes of IFN identified in mammalians: type I (IFNα and
IFNβ), type II (IFNγ), and type III (IFNλ 1/2/3) (Sadler and Williams, 2008). Fish IFNs are
classified into two groups: group I and group II (Zhang and Gui, 2012). Group I consist of IFNs
that contain 2 cysteine residues that is further divided into subgroup-a and -d whereas group II
contains 4 cysteine residues and is divided into subgroup-b and -c (Zou et al., 2007; Chang et al.,
2009). Rainbow trout specifically contain two additional subgroups denoted -e and -f, identified
by Zou et al. (2007) and have a remarkably large repertoire of type I IFNs consisting of 22 different
members to date. Fish IFN1 belongs to group I of type I IFNs and is upregulated in response to
both viral infections and polyI:C, in vitro and in vivo (Purcell et al., 2009; Zou et al., 2007). IFN1
is then able to induce the production of several hundred interferon stimulated genes (ISGs) to
prevent viral infections (Plantanias, 2005). For example, stimulation of IFN1 in rainbow trout by
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IHNV upregulated the expression of the ISG Mx protein to prevent viral replication both in vitro
and in vivo (Chang et al., 2009; Cao et al., 2016).

Viral and synthetic mimics of dsRNA are both potent inducers of type I IFNs, with as little as
one molecule of dsRNA being enough to induce an IFN response (Marcus, 1981). In mammals,
the activation of IRF3 and IRF7 through phosphorylation, dimerization, and nuclear translocation
prompts the production of IFN by first stimulating the IFN promoter regions. Following secretion
of IFN, the surface membrane-bound IFN-alpha/beta receptor (IFNAR) recognises and binds the
IFNs and initiates the Janus kinase signalling pathway (JAK-STAT) (Figure 2). The IFNAR
consists of two chains, IFNAR1 and IFNAR2 (Collet, 2014). Binding IFN triggers the recruitment
of kinases TYK2 and JAK1, which in turn promotes the phosphorylation of the STAT1 and STAT2
proteins (Langevin et al., 2013). The STAT proteins then form a heterodimer that conjugates with
IRF9 to form a complex known as IFN-stimulated gene factor 3 (ISGF3). This complex initiates
the transcription of ISGs after the binding of nuclear IFN-stimulated response elements (ISRE) of
ISGs (Langevin et al., 2013).
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Figure 2. Schematic showing type I IFN signalling to induce expression of ISGs. Type I IFN binds
to IFNAR1 and IFNAR2 to initiate the JAK-STAT signalling pathway by receptor
phosphorylation that is directed by two members of the JAK kinase family, JAK1 and TYK2.
JAK1/TYK2 phosphorylate and activate STAT1 and STAT2 proteins which then interact with
IRF9 to form the ISGF3 complex. Once inside the nucleus ISGF3 binds to ISREs of target gene
promoters to activate the transcription of ISGs. Figure produced in Biorender and adapted from
Green et al., 2018.

1.4 Interferon Stimulated Genes (ISGs)
ISGs are a group of antiviral proteins whose expression is induced by IFN and whose effect is
to establish an antiviral state. The JAK-STAT pathway creates the complex ISGF3 that binds to
ISREs to initiate the transcription of ISGs, inducing a multitude of antiviral genes. ISGs are an
essential component of innate antiviral immune responses as they work to limit viral replication at
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all steps (Poynter and DeWitte-Orr, 2016). These proteins are even kept at low levels in healthy
cells to maintain a thriving environment by being ready to attack at a moment’s notice, whereas
some ISGs are kept in inactive forms until cells become infected (Schneider et al., 2014). Recent
research has also shown that many ISGs are also direct targets of IRFs (IRF1, 3, and 7), IL-1, and
NFκB, and can even be induced without IFN signaling (Green et al., 2018).

1.4.1 Mx Proteins
The Mx group of proteins are dynamin-like GTPases that work to prevent viral infection. These
ISGs prevent viral replication through a range of different functions such as endocytosis,
mitochondrial distribution, and intracellular vesicle transport (Lee and Vidal, 2002). Mx proteins
have a highly conserved N-terminal GTPase domain and a GTPase effector domain (GED) that
contains 2 leucine zippers across species (Lee and Vidal, 2002). Similar to mammalian Mx
proteins, fish Mx’s are also induced by IFN (Alvarez-Torres et al., 2013). Mx protein expression
can be found in virtually all fish tissues after a viral infection, showing that its actions are systemic
in nature (Collet, 2014). Rainbow trout specifically express three Mx proteins, denoted -1, -2, and
-3, with Mx1 and Mx3 being localized to the cytoplasm and Mx2 in the nucleus (Trobridge et al.,
1997; Leong et al., 1998). Mx1 specifically forms oligomers around the nucleocapsid of certain
viruses targeting them for destruction (Melén et al, 1992). Mx1 is a crucial element in the rainbow
trout’s immune response to viral hemorrhagic septicemia virus (VHSV) where it correlates with
the up regulation of IFN to convey an early non-specific response to viral infections (Campbell et
al., 2011). The induction of Mx proteins is rapid but is maintained over long periods of time to
allow for the slow adaptive immune responses to develop for long term protection in fish (Collet,
2013).
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1.4.2 Vig3
VHSV induced gene 3 (vig3) in rainbow trout, also known synonymously as ISG15 in other
vertebrates, is a small ubiquitin-like protein. It contains two ubiquitin-like domains as well as a
highly conserved C-terminal LRGG sequence that is essential for binding of host and viral proteins
(Álvarez-Torres et al., 2018). Vig3 binds covalently to its target using ISGylation in a three-step
enzymatic cascade shown in Figure 3 (Skuag and Chen, 2010). ISG15 is also present in a nonconjugated form, both intracellularly and extracellularly. It works to negatively regulate the
expression of proinflammatory cytokines and chemokines as well as works to mediate the
regulation of IFNα and IFNβ to prevent auto-inflammation (Álvarez-Torres et al., 2018). ISG15
is a multifunctional protein as it can also function as a cytokine-like protein to induce IFNγ
expression in T-cells, as well as stimulate natural killer cell proliferation, or induce dendritic cell
maturation and neutrophil recruitment (D’Cunha et al., 1996). ISG15 has been identified in a
multitude of fish species and its expression is stimulated by IFN, as well as polyI:C, viral, and
bacterial infections (Røkenes et al., 2007; Seppola et al., 2007). ISG15 protein expression is
upregulated in fish infected with VHSV and IHNV, as well as grouper nervous necrosis virus
(GNNV) (Álvarez-Torres et al., 2018). Røkenes et al. (2007) have also demonstrated that Atlantic
salmon produce ISG15 in response to infection with IPNV and ISAV as well as polyI:C suggesting
its role to effectively combat viral pathogens.
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Figure 3. Schematic showing the 3-step enzymatic pathway of ISGylation. ISG15, or vig3, is
activated by the enzyme UBE1L, which is ATP-dependent. Next ISG15 is transferred to the second
enzyme UBCH8 and then to the third enzyme HERC5. ISG15 will then bind to its target using
lysine (K) through a C-terminal glycine-glycine motif. The ISG-ylation pathway bears many
similarities to the ubiquitination pathway. Figure produced in Biorender and adapted from Skuag
and Chen, 2010.

1.4.3 IRF-7
IRFs comprise a family of transcription factors that play a major role in the regulation of innate
immune responses upon viral infection (Tamura et al., 2008). To date there have been 10 members
of IRFs identified in higher vertebrates ranging from IRF1-IRF10, although not all species have
all 10 with some being lost or non-functional in some species (Bergan et al., 2010). IRFs can be
further divided into four subfamilies: IRF1-G (IRF1, IRF2), IRF3-G (IRF3, IRF7), IRF4-G (IRF4,
IRF8, IRF9, IRF10), and IRF5-G (IRF5, IRF6) (Bergan et al., 2010). The IRF3-G family is of
importance regarding the innate immune response, whereby IRF3 and IRF7 are important factors
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in the induction of type I IFNs (Panne, 2008). IRF3-G’s contain several serine residues at the Cterminus that become phosphorylated upon detection of a viral infection and constitute the virus
activated domain (VAD) (Marie et al., 2000). Detection of the viral pathogen triggers signaling
cascades leading to the activation of IRF3 and IRF7, where they are translocated to the nucleus
and bind with the ifnb promoter that subsequently initiates the production of IFN-β, which will
protect the cells from viral infections by inducing the production of ISGs and creating an antiviral
state (Bergan et al., 2010). IRFs, such as IRF-7, are also ISGs themselves (Ning et al., 2011).

1.5 Antiviral State
An antiviral state is an essential component of the innate immune system to halt pathogen
infection. The antiviral state is a by-product of IFN production and accumulation of ISGs to
prevent viral infection. Once viruses have been recognized by PRRs, signal transduction pathways
are activated to initiate the transcription of IFNs, cytokines that induce early warning signals to
pathogens (Dahle and Jørgensen, 2019). IFNs then stimulate the production of ISGs using the
JAK-STAT signaling pathway to stop the replication of viruses at different stages such as
translation of proteins, packaging of proteins, replication and budding (Poynter and DeWitte-Orr,
2016). An antiviral state can also be stimulated with synthetic immunomodulators such as polyI:C,
and a cell in an antiviral state is considered refractive to most virus infections (Dewitte-Orr and
Mossman, 2010).

1.6 Nanoparticles
Nanoparticles (NPs) are becoming more widely studied as therapeutic platforms in the
aquaculture industry. NPs are described as a material having at least one dimension between 1 and
100nm (Palmberg et al., 2009). These small particles have an increased surface area to volume
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ratio resulting in novel physical-chemical properties that are not seen in their larger counterparts
(Nel et al., 2006). The size, shape, and surface charge of the material ultimately determines the
ability of the NP to enter organisms, tissues, and cells. Although there are multiple routes of entry
for NPs, such as micropinocytosis, phagocytosis, diffusion, and adhesion, it is probable that
smaller NPs enter via diffusion or endocytosis and larger NPs are imported via phagocytosis (De
Lima et al., 2012; Conner and Schmid, 2003). Nanoparticles are used for a variety of different
applications in aquaculture, from the detection of aquatic diseases, pond sterilization, and the
delivery and enhancement of drugs and nutrients (Huang et al., 2015).

The most commonly used nanoparticles to date for industrial and research purposes are metal
NPs, specifically titanium dioxide (TiO2), zinc oxide (ZnO), cerium oxide (CeO2), silver (Ag), and
gold (Au) (Baker et al., 2014; Teles et al., 2019). However recent studies have shown that the
accumulation of the above metallic NPs may be extremely toxic to aquatic species causing
genomic instability, embryonic developmental abnormalities, and respiratory stress (Miranda et
al., 2016). Several different routes of entry have been hypothesized to cause these effects. For
example, NPs may enter cells through endocytosis, by diffusing through pores, or simply binding
to the cells surface and blocking membrane and pore functions (Baker et al., 2014). Specifically,
it was shown that Ag NPs can cause severe toxicity in rainbow trout during early and later life
phases. Johari et al., (2013) exposed rainbow trout (larvae, 2 days post-hatching, and juvenile) to
Ag NPs and found that they expressed reduced blood plasma chloride and potassium and elevated
cortisol levels. This can be extremely detrimental to fish health as elevated cortisol can weaken
innate immune responses by redirecting energy to stress responses (Braithwaite and Ebbesson et
al., 2014). Therefore, nanomaterials formed from natural polymers may provide a more useful and
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safer alternative to the toxic metallic NPs being studied in the aquaculture industry (Luis et al.,
2019).

1.6.1 Phytoglycogen Nanoparticles
PhG NPs may represent a safer and more natural alternative to metal nanoparticles used in the
aquaculture industry. The PhG NPs in question were developed by Dutcher et al., (2017) as a waste
by-product from a multistep chemical procedure. It was soon realized that these NPs are a
phytoglycogen that is naturally produced by sweet corn and rice, making it a promising non-toxic
alternative to other, more harmful NPs (Dutcher et al., 2017). The tradename of these PhG NPs is
NanodendrixTM (NDx). NDx exhibits a highly branched dendrimeric structure resulting in very
compact, monodisperse NPs (Figure 4. a and b). Another favourable aspect of phytoglycogen NPs
is that it is biodegradable and can be broken down into simple sugars in aquatic settings, as opposed
to most metal nanoparticles, which can bioaccumulate in aquatic environments (Luis et al., 2017).
It was hypothesized by Alkie et al., (2019) that cationic PhGs may increase the efficacy of polyI:C
delivery to enhance innate immune responses and limit viral replication in aquatic vertebrates, by
increasing IFN and ISG production. This was indeed the case in multiple rainbow trout cell lines
such as RTgutGC and RTG-P1 (Alkie et al., 2019). The mechanism of entry for polyI:C-NPs
appears to be via class A scavenger receptors, suggesting polyI:C-PhGs are brought to the
endosome from the cell surface (Alkie et al., 2019). It is likely that in the endosome, poly I:CPhGs are sensed by TLR3. Thus, one explanation for why phytoglycogen NPs bound to polyI:C
can induce stronger innate immune responses than polyI:C alone is that it may cause TLR3 homoclustering (Alkie et al., 2019). Receptor clustering can be facilitated by either homo-clustering,
binding to only one type of receptor, or hetero-clustering, binding to multiple different receptors
to increase uptake or potentially endocytosis (Figure 5) (Deci et al., 2017). Although
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phytoglycogen NPs do not increase antiviral immune responses on their own, they can effectively
increase the antiviral immune responses of polyI:C by increasing IFN and ISG levels, providing
an alternative therapeutic in aquaculture.

a)

b)

Figure 4. a) Schematic of a highly branched phytoglycogen nanoparticle. Image within blue circle
indicates that the nanoparticle consists of glucose monomers bonded by α-1,4-glycosidic linkages
and branching (approximately every 13 monomers) using α-1,6-glycosidic linkages. b) Twodimensional cross-sectional view of the protein structure of a highly branched phytoglycogen
nanoparticle. Figure adapted from Nickels et al., 2016.

Figure 5. Nanoparticles may mediate receptor clustering which can cause either homo-clustering
of particles to one type of receptor or hetero-clustering of particles to multiple, different receptors.
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This can facilitate increased uptake, endocytosis, as well as downstream signalling. Figure adapted
from Deci et al., 2017.

1.7 Viral Pathogens
1.7.1 Infectious Salmon Anaemia Virus
The orthomyxovirus, Infectious Salmon Anemia Virus (ISAV), is a virus that is of concern
globally, affecting fish farms in Norway, Canada, UK, USA, Chile, and the Faroe Islands (Crane
and Hyatt, 2011). ISAV is the etiological agent of infectious salmon anemia (ISA) and is
responsible for severe anemia, lethargy, ascites, haemorrhagic liver necrosis as well as
exophthalmia (Rimstad and Mjaaland, 2002). These clinical signs of ISA may not present
themselves until adverse environmental conditions or stress such as fluctuations in water
temperature or poor water quality occur, by which time it may be too late to overcome (Dannevig
and Thorud, 2011). This virus is not only of concern to Atlantic salmon, as it has also been shown
to infect other fish species in vitro, such as herring (Clupea harengus), rainbow trout
(Oncorhynchus mykiss), and coho salmon (Oncorhynchus kitsutch) (Nylund et al., 2002; Snow et
al., 2001; Kibenge et al., 2001). Although no mortalities have been reported in these species from
ISA, they can be considered potential carriers or reservoirs for ISAV infection (Kibenge et al.,
2009). ISAV belongs to the Orthomyxoviridae family and have a negative-sense segmented
ssRNA genome (Aamelfot et al., 2014). ISAV’s genome specifically is organized as eight
negative-sense ssRNA segments that encodes for 10 proteins (Mjaaland et al., 1997). Of the 10
proteins four of them comprise the major structural proteins: haemagglutinin esterase (HE), fusion
(F), nucleoprotein (NP) and the matrix (M) protein (Aamelfot et al., 2014). The HE protein is
involved in receptor binding and uses receptor-mediated endocytosis to enter the cell (Krossøy et
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al., 2001). The lowering pH in the endosome triggers the F protein to be cleaved into two proteins
(F1 and F2), exposing a fusion peptide that facilitates fusion between the viral envelope and the
endosomal membrane (Aspehaug et al., 2009). Replication of the ISAV genome occurs in the
nucleus of host cells, where it steals 5’ ends from capped host nuclear mRNA so that the host cell
will favour transcription of the viral genome (Sandvik et al., 2000). It has been suggested that the
main route of entry for ISAV is through the gills, however more recently it has been detected at
other mucosal surfaces such as the skin and gastrointestinal tract (Rimstad and Markussen, 2019).

1.8 Rainbow Trout
Oncorhynchus mykiss, more commonly referred to as rainbow trout, is a cold-water salmonid
fish species native to the Pacific Ocean in North America and Asia. Rainbow trout were introduced
from the Pacific Ocean to the Great Lakes and are currently housed and farmed globally making
them available worldwide and year-round for research, recreational, and commercial purposes.
Rainbow trout are adaptable to unexpected temperature fluctuations in both marine and freshwater
environments making them easy to maintain in aquaculture (Wolf and Rumsey, 1985). This species
of fish is economically important to Ontario, as it is the largest producer of rainbow trout in
Canada, producing about 5,416 tonnes in 2018 with a farm-gate value of $29.0 million (Moccia et
al., 2019). For this reason, it is imperative that rainbow trout are a well understood species at the
immune level to ensure that they remain viable as a food source. Rainbow trout have well
characterized innate immune responses and rely heavily on their non-specific immunity as a vital
defence mechanism against invading pathogens (Uribe et al., 2011). Rainbow trout are also
susceptible to almost all infections that afflict other salmonid species, especially the etiological
agents of Whirling disease and Viral Hemorrhagic Septicemia (VHS) that are prominent in Europe
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and North America (Wolf and Rumsey, 1985). These aspects of rainbow trout make them perfect
candidates for studying the effects of various pathogen infections on their innate immune systems.

1.9 Atlantic salmon
Atlantic salmon (Salmo salar) is salmonid species which is native to the north Atlantic Ocean
being commonly found in Cape Breton Island, mainland Nova Scotia, New Brunswick as well as
the northeast US coast. Commercial salmon farming started in Norway in the 1970s and since
expanded to many parts of the world including Canada (Houston and Macqueen, 2018). In Canada,
the main method of salmon aquaculture is with net pens or sea cages. In this method they are
farmed in two stages, the first occurring inland in freshwater tanks where they are hatched from
eggs. At about 12 to 18 months old the smolts are transferred to floating, anchored, and sheltered
net pens in salt water where they are left for another 12 to 24 months when they are harvested. The
majority of Atlantic salmon farming occurs in four countries: Norway, Chile, Scotland, and
Canada (Iversen et al., 2020). It is therefore imperative that the immune response of these animals
is well understood to prevent pathogenic outbreaks, as many other countries rely on these four
countries as a source of salmon.

1.10 Research Objectives and Hypotheses
The objectives of this research project were to determine the efficacy of a novel phytoglycogen
nanoparticle bound to polyI:C as an innate immune stimulant in rainbow trout and Atlantic salmon
to combat viral infections. The first objective was to determine the effectiveness of polyI:C-PhG
to stimulate IFNs and ISGs in the gut and head kidney of rainbow trout and Atlantic salmon when
fed orally by oral gavage or with synthesized fed pellets. The second objective is to determine if
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polyI:C when bound to PhG NPs can effectively prevent viral replication in Atlantic salmon
infected with ISAV with fed feed pellets containing polyI:C-NDx incorporated into them. Based
on prior in vitro data, it was hypothesized that polyI:C-NDx would be able to stimulate higher
innate immune responses, through the induction of IFN and ISGs, than polyI:C alone in both
rainbow trout and Atlantic salmon. This nanoparticle complex was hypothesized to be capable of
inducing both local and systemic innate immune responses. It was also hypothesized that the
induction of antiviral innate immune responses would be sufficient to prevent viral replication
after a cohabitation infection with ISAV.
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Chapter 2. Materials and Methods
2.1 PolyI:C and Phytoglycogen nanoparticle formulations
The cationic phytoglycogen nanoparticles (PhG NPs), tradename NanodendrixTM (NDx),
which are manufactured by GlysantisTM (Guelph, ON, Canada) were used to deliver high molecular
weight polyI:C. PolyI:C has a negatively charged phosphate backbone that can bind by electrostatic
interactions with positively charged PhG NPs. High molecular weight polyI:C (Catalog# tlrl-pic,
HMW), a synthetic dsRNA, was obtained from InvivoGen and resuspended at 1mg/mL in molecular
biology grade water according to the manufacture’s recommendations. The cationic PhG NPs was also
dissolved in molecular biology grade water at a concentration of 1mg/mL. In all experiments, PhG
NPs and polyI:C HMW aliquots were stored at -20oC and were thawed and heated at 55oC for 20
minutes prior to conjugation. The polyI:C and NDx complex was formed with a ratio of 1:1 (w/w)
assuming 100% (w/w) theoretical loading of the NPs, where all polyI:C is bound to the cationic
phytoglycogen NPs. Then 10μl from 100μg/mL NPs were mixed with 40μL of 25μg/mL polyI:C
which was pipetted to mix and incubated for 20 minutes at room temperature to allow for electrostatic
interactions to occur between the negatively charged polyI:C and cationic NPs (Alkie et al., 2019).

2.2 Oral gavage and feed pellet formulations
For the oral gavage trial, commercially available rainbow trout feed pellets (Bluewater
Feed Company Ltd, ON, Canada) were ground into a fine powder using an electric coffee grinder
(Black and Decker, MA, USA). One gram of ground feed was placed into a 1ml surgical syringe
and moistened with 750L of water, polyI:C, or polyI:C-NDx so that fish receiving treatment feeds
received a dosage of 250g polyI:C or 250g polyI:C bound to 250g NDx, based on a 2% body
mass feeding.
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For the feed pellet trials, 150g rainbow trout feed pellets (Bluewater Feed Company Ltd,
ON, Canada) were ground into a fine powder using an electric coffee grinder (Black and Decker,
MA, USA) and transferred to a KitchenAid stand mixer (KitchenAid, OH, USA) where they were
combined with a solution containing 150mL of the target products until a smooth and thick paste
was formed. The dough-like paste was then transferred to a pasta maker which produced feed
strands 0.2mm in diameter, which was laid out on tinfoil, air dried, and hand cut into round feed
pellets. The fish were fed daily based on a diet of 2% body mass, with commercial feed
supplemented in-between treatments, and to ensure a full dosage was received the fish were starved
for 3 days prior to treatment. This dosage was determined from a previous study conducted in vitro
using rainbow trout gut cell lines (Alkie et al., 2019). For the salmon trial the pellets were made
using the same method with a commercially available salmon feed EWOS ® Transfer Feed 1.52mm (EWOS® Cargill, Surrey, BC, Canada).

2.3 Rainbow Trout Oral Gavage Trial
Ninety Rainbow trout were purchased and transferred from Rainbow Springs Hatchery
(Thamesford, ON, Canada) to Wilfrid Laurier University’s animal care facility where they were
stored in polyethylene tanks containing 450L of aerated water that utilized a flow through system
of 12oC well water. Each day water quality was checked to ensure a constant temperature of 12 oC,
a % Dissolved oxygen (DO) of 80%, a water pH of 7.5 and as well as visual checks of their
swimming patterns to ensure the fish were healthy. Fish were pre-weighed before being distributed
between 3 tanks to ensure an even distribution of weight per tank, with the average mass being
50g with 30 fish/tank. The trout were allowed to acclimate for two weeks before the experiment
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began and three days before the experiment the fish were restricted feed. Prior to receiving the oral
gavage, trout were anesthetized in aerated water buckets containing 100mg/L tricaine
methanesulfonate (MS-222, Syndel, Port Alberni, BC, Canada) buffered with 200mg/L NaHCO3.
Each trout received an oral gavage of ground feed moistened with the treatment of either water
(mock), polyI:C, or polyI:C-NDx. At 24 hours post-oral gavage 10 fish from each group were
euthanized with 1.5g/L MS-222 buffered with 3g/L NaHCO3 and portions of the middle intestine
and head kidney were collected and stored in TRIzol reagent (Invitrogen, Thermo Fisher
Scientific) and RNAlater respectively, and samples were stored at -20oC for future use. At 48 hours
post the first oral gavage and 24 hours and 7 days post a second gavage (Figure 6), 10 trout were
euthanized per group per time point with middle intestine and head kidney being collected as
previously described. No mortalities were associated with treatment feedings.

a)
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b)

Figure 6. a) Schematic representation of the in vivo oral gavage trial. Fish were acclimated to their
new environment 2 weeks before the start of the first treatment feeding of either mock (water),
polyI:C, or polyI:C-NDx. Ten fish were euthanized per time point per tank on days 2, 3, 4, and 10
following the start of the trial. b) Schematic representation of the tank set up utilized in the oral
gavage trial. Three well-water tanks housed 30 trout each over the course of the experiment
labelled water, polyI:C, and polyI:C-NDx.

2.4 Rainbow trout feed pellet trial #1
One-hundred and five rainbow trout were collected and transported from Lyndon Fish
Hatcheries (New Dundee, ON, Canada) to Wilfrid Laurier University’s animal care facility where
they were stored in polyethylene tanks containing 450L of aerated water that utilized a flow
through system of 12oC well water. The fish were evenly distributed between three tanks labelled
water (mock), polyI:C, and polyI:C-NDx so that the mass weight per tank was 90g with 35
fish/tank. Before the experiment began the trout were allowed to acclimate for 2 weeks, and three
days before were restricted feed to ensure they would uptake the novel feed pellets. Fish were feed
a measured quantity of feed based on a 2% body mass diet. Twenty-four hours after the first
treatment feed 7 fish were euthanized per tank by submersion in water supplemented with 1.5g/L
MS-222 buffered with 3g/L NaHCO3. Portions of the middle intestine and head kidney were
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extracted and stored in 700μl of TRIzol reagent or RNAlater and stored at -20oC until future use.
Middle intestine and head kidney were also extracted at 48 hours post the first treatment feed.
Following the first treatment feed, 48 hours later a second treatment was given with middle
intestine and head kidney being sampled. Post the second treatment feed, a third feed was given 4
days later and 7 days post the final feeding (Figure 7) middle intestine and head kidney were
collected and stored in TRIzol reagent or RNAlater at -20oC. No mortalities were associated with
treatment feedings.

a)

b)

Figure 7. a) Schematic representation of the first in vivo feed pellet trial. Fish were acclimated to
their new environment 2 weeks before the start of the first treatment feeding of either mock (water),
polyI:C, or polyI:C-NDx. Seven fish were euthanized per time point per tank on days 2, 3, 5, and
14 following the start of the trial. b) Schematic representation of the tank set up utilized in the first
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fed pellet trial. Three well-water tanks housed 35 trout each over the course of the experiment
labelled water, polyI:C, and polyI:C-NDx.

2.5 Rainbow trout feed pellet trial #2
The Wilfrid Laurier University’s animal care facility was used to house 120 rainbow trout
from Lyndon Fish Hatcheries (New Dundee, ON, Canada). The 120 trout were evenly distributed
into four tanks labelled water (mock), polyI:C, polyI:C-NDx, and NDx so that the average mass
of the fish per tank was 20g, with 30 fish/tank. The tanks used to house the trout over the course
of the experiment were 450L polyethylene tanks with a flow through system of aerated well water,
that sustained a constant temperature of 12oC. The trout were acclimated to their new environment
for two weeks, and three days before the beginning of the feed trial all feed was restricted to ensure
that the trout would intake the formulated feed pellets. The trout were feed 3 treatment feeds
throughout the course of 15 days with commercial rainbow trout feed being supplemented in
between treatment feeds. Twenty-four hours after the first treatment feed 6 fish were euthanized
per group by submersion in 1.5g/L MS-222 buffered with 3g/L NaHCO3. Following euthanization
portions of middle intestine and head kidney were collected and stored in TRizol reagent or
RNAlater and stored at -20oC for future use. Four days following the first feeding a second
treatment feed was delivered, and 3 days following the second feeding the third and final treatment
feed was delivered. Twenty-four hours after the second treatment, 24 hours after the third treatment
and 9 days after the third treatment feed (Figure 8), 6 trout were euthanized per group per time
point with middle intestine and head kidney being collected as previously described. No mortalities
were associated with treatment feedings.
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a)

b)

Figure 8. a) Schematic representation of the second in vivo feed pellet trial. Fish were acclimated
to their new environment 2 weeks before the start of the first treatment feeding of either mock
(water), polyI:C, polyI:C-NDx or NDx. Six fish were euthanized per time point per tank on days
2, 6, 9, and 17 following the start of the trial. b) Schematic representation of the tank set up utilized
in the second feed pellet trial. Four well-water tanks housed 30 trout each over the course of the
experiment labelled water, polyI:C, and polyI:C-NDx, and NDx.

2.6 Atlantic salmon feed pellet trial
One-hundred twenty Atlantic salmon with an average mass of 100g were purchased from
Cardigan Fish Hatchery (Cardigan, PEI, Canada) through MOWI Canada East (New Brunswick,
Canada) and transported to and stored at the AVC Aquatic Animal Facility at the University of
Prince Edward Island (PEI, Canada). Here they were stored in 300L tanks with a fresh-water
single-pass flow through system prior to smoltification and then an artificial sea water (Instant
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Ocean, Blacksburg, Virginia, USA) closed recirculating system was used post smoltification. The
fish were tagged with passive integrated transponders (PIT) upon arrival with anesthetization in
100 mg/L of MS-222 and a small incision was made with a scalpel blade and the PIT tag was
inserted into the peritoneal cavity and fish were allowed to acclimate for 2 weeks. Following
acclimation, the fish were transferred to 8 artificial saltwater tanks and were left to acclimate for
another 2 weeks. One day before the start of the experiment the salmon were restricted feed to
ensure uptake of the treatment feed. All fish received either the mock feed, commercial feed pellets
that were reformulated with water, or the treatment feed, commercial feed pellets reformulated
with polyI:C-NDx. Twenty-four hours following the feeding, 5 fish each were selected from two
of the control tanks and two of the treatment tanks and were euthanized and portions of the middle
intestine and head kidney were collected and stored in RNAlater to later examine the effects on
the innate immune response. Two days later 3 salmon that had been intraperitoneal (IP) injected
with ISAV were introduced into the control and treatment tanks. Fish were IP injected with 100l
of ISAV-HPR4 RPC/NB 04-085-1 (1x104 TCID50) from Fisheries and Oceans Canada (Moncton,
NB, CA) using a 1ml syringe and 26-gauge needle. Following the cohabitation of the infected fish
into the tanks, the salmon were feed 3 more times with the novel feed pellets at 2-, 5- and 10-days
post cohabitation. At 21 days from the start of the first treatment feed, all remaining fish were
euthanized, and portions of the middle intestine were collected and stored in RNAlater at -20oC to
later observe the viral load in the samples.
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a)

b)

Figure 9. a) Schematic representation of the Atlantic salmon in vivo feed pellet trial. Fish were
PIT tagged upon arrival and acclimated in fresh water for two weeks. Post smoltification fish were
transferred to salt-water tanks 2 weeks before the start of the first treatment feeding of either mock
(water) and polyI:C-NDx. Five fish were euthanized per group on day 2 and the remaining live
fish were euthanized on day 21. b) Schematic representation of the tank set up utilized in the
salmon feed pellet trial. Eight salt-water tanks housed 15 salmon each over the course of the
experiment labelled control and polyI:C-NDx.
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2.7 RNA Extraction and cDNA Synthesis of Rainbow Trout Tissue
Tissue samples were transferred to 1.5mL Sterile Screw Cap MicroTube with Conical Base
and O-Ring Cap (Sarstedt, Newton, NC) with 700l of TRIzol® Reagent (Invitrogen, Thermo
Fisher Scientific) and zirconium oxide beads. Tissue samples were then homogenized using a
Percellys® 24 Bead Mill Homogenizer at 6400rpm for 2 cycles of 15 seconds. RNA was extracted
using the manufacture’s protocol. Total RNA concentration for each sample was determined using
the Nanodrop Lite Spectrophotometer (Thermo Fisher Scientific) and then stored at -80oC until
future use. RNA samples were Dnase treated using Turbo DNA-freeTM Kit to eliminate any
contaminating DNA following manufacture’s protocols (Invitrogen, Thermo Fisher Scientific) and
then cDNA was synthesized from 500ng of purified RNA using 5x iScriptTM Reverse Transcription
Supermix for RT-qPCR (Bio-Rad Laboratories) according to the manufacture’s protocols. Once
reactions were complete, cDNA was diluted 1:10 in nuclease free water and stored at -20oC until
future use in qPCR.

2.8 qPCR of Rainbow Trout Intestine and Head Kidney
The expression of antiviral response genes such as IRF7, IFN1, Mx1, and Vig3 transcripts
were detected by SYBR Green real time PCR using Hard-Shell® 96-well plate PCR plates (BioRad) and quantified by the CFX Connect Real-Time PCR Detection System (Bio-Rad). All qPCR
reactions contained: 5l of SsoFastTM EvaGreen® Supermix (Bio-Rad Laboratories), 0.2l each
of the forward and reverse gene primers (Sigma-Aldrich), 0.6l of nuclease-free water and 4l of
1:10 diluted cDNA. Plates were sealed using optically clear plate sealing adhesive (Bio-Rad). The
conditions in which all qPCR reactions were run are listed in Table 1. All gene primers utilized
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are listed in Table 2. β-actin was utilized as the house keeping gene as it showed the greatest
stability with cycle threshold (Ct) values maintaining consistency between groups, with a melt
curve being generated for each PCR reaction to confirm the specificity of the primers. The ∆∆Ct
method was employed to analyse the expression levels of the target genes, relative to β-actin and
normalized to the control and represented as the fold change over the control. Replicate tanks were
not used in the studies due to limited availability and space for housing fish.

Table 1. qPCR conditions of all tissue samples for detection of IFN and ISG transcripts
PCR Step
Initial Denaturation
Denaturation
Amplification
Melt Curve

Conditions
98oC, 2 minutes
98oC, 5 seconds
55°C, 10 seconds
95°C, 10 seconds
65°C-95°C, every 5 seconds

Cycle Number
1
40
-

Table 2. Primers sequences and their annealing temperatures used for qPCR.
Gene Name
β - actin
Rainbow trout
IFN1
Mx1
Vig3
β - actin
Atlantic
salmon
IRF7

Sequence
F- GTCACCAACTGGGACGACAT
R- GTACATGGCAGGGGTGTTGA

Reference
Poynter et al. 2015

F- AAAACTGTTTGATGGGAATATGAAA
R- CGTTTCAGTCTCCTCTCAGGTT
F- CGGAGTTCGTCTCAACGTCT
R- CCCTTCCACGGTACGTCTTC
F-ACCCAGTTCAAAGCCAAGGT
R-CCCTCGTGAATCAGCCTCTG
F: CCAAAGCCAACAGGGAGAAG
R: AGGGACAACACTGCCTGGAT

Poynter et al. 2015

F: GTCGTCAAGGTGGTTCCCCT
R: TGGGAGATCTGCAGGCTGAT
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Poynter et al. 2015
Poynter et al. 2015
Olsvik et al. 2005

Sun et al. 2011

2.9 Probe based qPCR for the detection of ISAV in Atlantic salmon middle intestine
Atlantic salmon cDNA samples from the middle intestine were prepared as described in
section 2.7. Twenty l reactions were prepared using 10l TaqManTM Gene Expression Master
Mix (Thermo Fischer, Vilnius, Lithiuania), 7l molecular biology grade water (VWR, Solon, OH),
1l Custom TaqMan® Gene Expression Assay (Thermo Fischer, Vilnius, Lithiuania; primer and
probe sequences found in Table 4) and 2l cDNA (1:10 diluted) and run in Hard-Shell® 96-well
plate PCR plates (Bio-Rad). These samples were quantified by the CFX Connect Real-Time PCR
Detection System (Bio-Rad) and compared against standards of 1:10 serially diluted ISAV-8
plasmid to determine the copy number of virus in the intestinal samples. Each sample was run in
duplicate, and all samples had Ct values <0.05 between replicates. Table 3 depicts the PCR
conditions in which the reactions were subjected to.
Table 3. qPCR conditions for probe-based qPCR of Atlantic salmon tissue samples.
PCR Step
Pre-Incubation
Denaturation
Amplification

Conditions
50oC, 2 minutes
95oC, 10 minutes
95°C, 15 seconds
60°C, 1 minute

Cycle Number
1
1
45

Table 4. Primer and probe sequences used for the detection of ISAV.
Gene Name
Upstream
primer
Downstream
primer
TaqMan Probe

Sequence (5’-3’)
CTACACAGCAGGATGCAGATGT

Amplicon Size (bp)
104

Reference
Barker et al.
2019

CAGGATGCCGGAAGTCGAT
FAM-CATCGTCGCTGCAGTTC-MGB

2.10 Statistical Analysis
Statistical analysis of all data was conducted using version 9 of Prism GraphPad
(GraphPad, La Jolla, CA). All data from the oral gavage, first feed pellet trial, and the salmon feed

45

pellet trial were analysed using an unpaired Student’s t-test, with a P-value of <0.05 indicating
statistical significance. A start system was utilized to indicate the level of significance with one
star (*) equaling a p-value <0.05, 2 stars (**) equaling a p-value of <0.01, and 3 stars (***)
equaling a p-value <0.001. Data from the second feed pellet trial was analysed using a one-way
ANOVA, using a Tukey’s post hoc test to determine the statistical significance between 3 groups.
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Chapter 3. Results
3.1 Antiviral gene expression in middle intestine and head kidney of rainbow trout fed by
oral gavage containing poly I:C or polyI:C-NDx
To determine the effects of the poly I:C-PhG NP complex on the innate antiviral immune
response on rainbow trout, IFN1, Mx1 and Vig3 transcript levels were measured in fish fed
polyI:C-NDx supplemented feed compared to fish fed polyI:C alone supplemented feed, delivered
by oral gavage. At 24 hours post the first oral gavage 6 out of 8 fish fed the polyI:C-NDx fed had
higher levels of IFN1 compared to the average transcript level for fish in the HMW group and Mx1
and 7 out of 10 fish with higher levels compared to the polyI:C average (Figure 10. a and b). The
transcript levels of Vig3 show that 5 out of 10 fish had higher levels of expression in comparison
to the polyI:C group average (Figure 10. c), with the highest responder of Mx1 and Vig3 being
about 4 and 6 times higher than that of the highest responder in polyI:C only respectively. Mx1
transcript levels were statistically significantly different between polyI:C and polyI:C-NDx
treatment groups. The innate immune response was also observed in the head kidney at 24 hours,
which shows a similar response with fish that received an oral gavage containing polyI:C-NDx
having higher expression levels of IFN1, and both ISGs although slightly weaker in comparison
to the intestine (Figure 10. d, e, f). Vig3 transcript levels were statistically significantly different
between poly I:C and poly I:C-NDx treatment groups. Forty-eight hours post the initial oral gavage
8 more trout were euthanized and their IFN1, Mx1, and Vig3 expression levels were measured and
compared between treatment groups. In the intestine, fish that received an oral gavage of feed
moistened with polyI:C-NDx on average expressed higher levels of IFN1, Mx1 and Vig3 with 5
out of 8 and 6 out of 8 fish being higher responders compared to the average transcript levels of
the polyI:C alone group for Mx1 and Vig3 respectively (Figure 11. a, b, c). IFN1 and vig3
transcript levels were statistically significantly different between poly I:C and poly I:C-NDx
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treatment groups. Although not statistically significant, the head kidney of fish fed the polyI:CNDx feed trended higher across all three genes (Figure 11. d, e, f), with the levels of expression
continuing to rise in comparison to the 24-hour data. After these fish were euthanized a second
oral gavage was administered to the remaining fish and 24 hours following this feeding 5 fish were
euthanized per group. At 24 hours post the second gavage the same trend is observed in the
intestine with polyI:C-NDx fed fish having higher levels of IFN1, Mx1, and Vig3 in comparison
to polyI:C fed fish (Figure 12. a, b, c). Vig3 transcript levels were statistically significantly
different between poly I:C and poly I:C-NDx treatment groups. At this time point the innate
immune response was also observed in the head kidney which shows a similar trend to the
intestine. For IFN1 5 out of 5 fish had higher transcript levels in comparison to the polyI:C alone
average (Figure 12. d). Mx1 and Vig3 also showed a similar trend to the intestine at 24 hours after
the second gavage, with 3 out of 5 fish and 4 out of 5 fish having higher transcript levels than the
polyI:C group average respectively (Figure 12. e and f). At the final time point of 7 days post the
second gavage, the polyI:C-NDx group fish have higher levels of expression of all innate immune
genes, with a few fish for each gene being higher responders than the rest (Figure 13. a, b, c).
Again, although not statistically significant the poly I:C-NDx treated fish tended to have higher
IFN1 and ISG expression levels compared to poly I:C alone. The same response is also observed
systemically in the head kidney for all genes however the levels of expression are slightly reduced
in comparison to the intestine (Figure 13. d, e, f). The weights of the trout were tracked throughout
the course of the trial, with Figure 14 depicting the weights at the start and end of the trial for all
three groups (water (control), polyI:C, and polyI:C-NDx). The water and polyI:C group
experienced a 3.6% and 16.8% decrease in weight respectively over the course of the trial whereas
the polyI:C-NDx fed fish experienced a 15.4% increase.
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a)

b)

c)

d)

e)

f)

Figure 10. Innate immune responses of rainbow trout 24 hours after an oral gavage of either
polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3 middle intestine
d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney. Differences in expression between
polyI:C and polyI:C-NDx was analyzed using an unpaired student’s t-test *p<0.05, **p<0.01,
***p<0.001.
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d)

b)
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e)

f)
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Figure 11. Innate immune responses of rainbow trout 48 hours after an oral gavage of either
polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3 middle intestine
d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney. Differences in expression between
polyI:C and polyI:C-NDx was analyzed using an unpaired student’s t-test *p<0.05, **p<0.01,
***p<0.001.
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d)
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c)

e)

f)

Figure 12. Innate immune responses of rainbow trout 24 hours after a second oral gavage of either
polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3 middle intestine
d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney. Differences in expression between
polyI:C and polyI:C-NDx was analyzed using an unpaired student’s t-test *p<0.05, **p<0.01,
***p<0.001.
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Figure 13. Innate immune responses of rainbow trout 7 days after a second oral gavage of either
polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3 middle intestine
d) Mx1 head kidney e) Vig3 head kidney. IFN1 levels were undetectable at this timepoint in both
groups in the head kidney. Differences in expression between polyI:C and polyI:C-NDx was
analyzed using an unpaired student’s t-test *p<0.05, **p<0.01, ***p<0.001.

Figure 14. Average weight of rainbow trout at the start of the oral gavage trial and at the end for
mock (water), polyI:C, and polyI:C-NDx fed fish.
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3.2 Antiviral gene expression in middle intestine and head kidney of rainbow trout for feed
pellet trial #1
The oral gavage method has the advantage of ensuring each fish received the same amount
of feed; however, this method is labour intensive, stressful, and not usable in a real-world
application. As such, feed pellets were made containing polyI:C-NDx or polyI:C alone and fed to
the fish to replicate a more realistic feed-based therapeutic delivery. Fish received a dosage of
either 250μg of polyI:C, 250μg of polyI:C bound to 250μg of NDx with a control group receiving
feed pellets reformulated with water. At 24 hours after the first feeding, 7 fish were euthanized per
group and the expression levels of IFN1 and two ISGs, Mx1 and Vig3, were compared to the
control group. At this time point fish that were fed the polyI:C-NDx feed on average had higher
levels of all three antiviral genes tested. Statistical significance was calculated using a student’s
unpaired t-test which produced a p-value of 0.0039 for IFN1 and a p-value of 0.0493 for Mx1
(Figure 15. a and b). Although no statistical significance was observed for Vig3 at 24 hours in the
middle intestine, 4 out of 7 fish fed polyI:C-NDx still had higher upregulated levels of expression
than the polyI:C alone group average (Figure 15. c). The systemic antiviral innate immune
response was also observed in the head kidney at 24 hours which showed Mx1 and Vig3 following
a similar trend of fish fed polyI:C-NDx on average stimulating higher production of the two genes,
with Mx1 ranging from 0.3 to 15-fold and Vig3 ranging from 0.6 to 35.5-fold (Figure 15. e and f).
IFN1 at 24 hours in the head kidney was not upregulated at this time point with no clear group as
being more responsive (Figure 15. d). Forty-eight hours following the first treatment an additional
7 fish were euthanized, and at this time point there was no detectable IFN1 transcripts in the
intestine in any of the fish groups. The Mx1 and Vig3 response, although not statistically
significant, showed similar trends with 5 out of 7 and 4 out of 7 fish of the polyI:C-NDx group
having higher levels of expression compared to the polyI:C alone group average of the two ISGs
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respectively (Figure 16. a and b). At 48 hours the innate immune responses were also observed
systemically in the head kidney which shows polyI:C-NDx fed fish expressing higher levels of
expression for all three genes (Figure 16. c, d and e). Following this time point the remaining fish
were fed a second treatment feed whereby 7 fish were euthanized 48 hours later. The immune
response in the intestine at this time point revealed that IFN1 transcript levels were significantly
higher in polyI:C-NDx fed fish with all of the fish (7 out of 7) having higher levels of expression
in comparison to polyI:C alone average where the highest responder in the polyI:C-NDx group
was 3x higher than the highest responder in the polyI:C group (Figure 17. a). This data was
statistically significant with a p-value of 0.0023. At this time point the Mx1 and Vig3 followed a
similar trend of polyI:C-NDx fish on average expressing higher levels of expression, although no
statistical significance was observed (Figure 17. b and c). In the head kidney, the innate immune
response was also analyzed 48 hours following a boost treatment feed. There was no detectable
IFN1 for any fish at this time point. The expression of Mx1 was also relatively lower for all fish
with one fish in the polyI:C-NDx group having a 20.48-fold change and one fish in the poly I:C
group having an 8.0-fold change (Figure 17. d). Vig3 also was relatively reduced for both groups
in comparison to the intestine response at this time point, with majority of the fish ranging from
0.09-1-fold change in expression whereby one fish in the polyI:C group expressed a fold change
of 55.3 (Figure 17. e). A third boost feed was given 48 hours following the second, with the
remaining fish being euthanized 7 days later. In the intestine, the IFN1 response has started to taper
off in comparison to the responses seen at earlier time points. Although the expression of IFN1 is
lower at this time point the polyI:C-NDx feed fish still experienced higher levels of IFN1 compared
to poly I:C alone (Figure 18. a), following the same trends of earlier time points. The Mx1 and
Vig3 response is also slightly lower than earlier time points of 24- and 48-hours after the first feed,
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however again it is observed that polyI:C-NDx fish experienced higher levels of expression in
comparison to polyI:C fish (Figure 18. b and c). At this time point there was no statistical
significance observed for any genes. Lastly in the head kidney it appears the systemic response
has started to decline, and no group of fish had stimulated expression of IFN, Mx1 and Vig3
(Figure 18. d, e, f). The weight of the rainbow trout was also assessed throughout the course of the
trial, with Figure 19 depicting the weights at the start and end of the trial for all three groups (water
(control), polyI:C, and polyI:C-NDx). The water and polyI:C fed fish experienced a 15.4% and
19.7% increase in wight respectively over the course of the trial however the polyI:C-NDx fed fish
experienced a much higher weight increase of 30.3%.
a)

d)

b)

c)

e)

f)

Figure 15. Innate immune responses of rainbow trout 24 hours after being fed pellets containing
either polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3 middle
intestine d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney. Differences in expression
between polyI:C and polyI:C-NDx was analyzed using an unpaired student’s t-test *p<0.05,
**p<0.01, ***p<0.001.
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Figure 16. Innate immune responses of rainbow trout 48 hours after being fed pellets containing
either polyI:C or polyI:C-NDx a) Mx1 middle intestine b) Vig3 middle intestine c) IFN1 head
kidney d) Mx1 head kidney e) Vig3 head kidney. IFN1 levels were undetectable at this timepoint
in both groups in the middle intestine. Differences in expression between polyI:C and polyI:CNDx was analyzed using an unpaired student’s t-test *p<0.05, **p<0.01, ***p<0.001.
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d)
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e)

Figure 17. Innate immune responses of rainbow trout 48 hours after a boost feeding of pellets
containing either polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c)
Vig3 middle intestine d) Mx1 head kidney e) Vig3 head kidney. IFN1 levels were undetectable at
this timepoint in both groups in the head kidney. Differences in expression between polyI:C and
polyI:C-NDx was analyzed using an unpaired student’s t-test *p<0.05, **p<0.01, ***p<0.001.
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Figure 18. Innate immune responses of rainbow trout 7 days after a third boost feeding of pellets
containing either polyI:C or polyI:C-NDx a) IFN middle intestine b) Mx1 middle intestine c) Vig3
middle intestine d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney. Differences in
expression between polyI:C and polyI:C-NDx was analyzed using an unpaired student’s t-test
*p<0.05, **p<0.01, ***p<0.001.
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Figure 19. Average weight of rainbow trout at the start of the first feed pellet trial and at the end
for mock (water), polyI:C, and polyI:C-NDx fed fish.

3.3 Antiviral gene expression in middle intestine and head kidney of rainbow trout for feed
pellet trial #2
A second feed pellet trial was performed to replicate trial #1. While sharing many
similarities, including polyI:C and polyI:C-NDx dosage, the differences between the trials were as
follows: the addition of a fourth treatment group of 250g NDx alone feed as well as a 10-day post
feed time point. At 24 hours after the first treatment feed the innate immune response was assessed
both locally in the middle intestine and systemically in the head kidney. The IFN1, Mx1, and Vig3
response all showed fish fed the polyI:C-NDx feed having higher levels of transcript expression
in comparison to polyI:C and NDx fed fish. Four out of 6 fed polyI:C-NDx had higher transcript
levels of IFN1 compared to both the polyI:C and NDx alone group averages (Figure 20. a). At this
time point 5 out of 6 fish and 3 out of 6 fish expressed higher levels of Mx1 and Vig3 respectively
in comparison to both the polyI:C alone and NDx alone group averages (Figure 20. b, c). The
response in the head kidney at 24 hours was not as defined, with no differences observed between
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groups with IFN1 expression (Figure 20. d). Mx1 and Vig3 in the middle intestine showed a slight
increase in expression levels for polyI:C-NDx fed fish (Figure 20. d and e). Twenty-four hours
following the second treatment feed, which occurred 4 days following the first treatment feeding,
IFN1, Mx1 and Vig3 gene expression was assessed in the middle intestine, which showed polyI:CNDx fed fish having higher levels of expression on average in comparison to polyI:C and NDx
feed. Four out of 6 fish expressed higher levels of expression of IFN1 with polyI:C-NDx treatment,
comparison to polyI:C and NDx feed fish transcript averages, ranging from 0.3 to 11.7-fold, with
Mx1 and Vig3 showing a similar trend (Figure 21. a, b, c). In the head kidney, there was no
detectable IFN1 for any of the treatment groups, however Mx1 and Vig3 responses follow the
trend expressed in the previous time point where polyI:C-NDx fed fish had a greater immune
response where the highest responder of Mx1 and Vig3 expressed a 14.6- and 12.6-fold change
respectively (Figure 21. d and e). The trout were fed a third and final treatment feed that occurred
3 days following the second feeding. Twenty-four hours following the final feeding 6 fish were
euthanized per group and their IFN1, Mx1, and Vig3 response was determined. At this time point
in the intestine polyI:C-NDx had the lowest antiviral innate immune response for IFN, Mx1 and
Vig3, with polyI:C only and NDx only fed fish having a similar immune response (Figure 22. a,
b, and c). PolyI:C and NDx group fish had slightly higher levels of expression for all three genes
with the highest responder of polyI:C and NDx for IFN1 being 6.3- and 6.2-fold respectively
(Figure 22. a). In the head kidney 24 hours following the third treatment feeds there was no
detectable IFN1 for any fish. The Mx1 response showed a similar trend to the earlier treatment
feeds, where polyI:C-NDx fed fish on average have higher expression levels with 2 fish being
considered higher responders with a 1.6- and 14.6-fold difference (Figure 22. d). The Vig3
response shows that at NDx had the highest overall levels of expression in comparison to polyI:C-
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NDx whereby two fish were considered higher responders (Figure 22. e). The final time point
studied occurred 10 days following the final treatment feed, which showed a similar trend in the
intestine to the previous time point where polyI:C-NDx had the lowest levels of expression for all
3 genes however on a smaller scale with expression beginning to taper off (Figure 23. a, b, c).
IFN1 in the head kidney does not have any group as being a clear higher responder with majority
of the fish being clustered at the 1- to 2-range of relative normalized expression (Figure 23. d).
Mx1 and Vig3 however follow the trend seen previously of polyI:C-NDx fed fish, having on
average a higher accumulation of ISGs with majority of the fish having a similar response for all
groups, whereby 3 out of 6 fish in the polyI:C-NDx group expressed higher levels of expression
of both ISGs compared to the average transcript level of polyI:C and NDx only fed fish (Figure
23. e and f). Statistical significance was calculated for all genes at all time points using a one-way
ANOVA, however no statistical significance was observed. The weights of the trout were also
assessed (Figure 24.), whereby the water group experienced a 16% decrease in body mass from
the start to end of the trial. The polyI:C, polyI:C-NDx and NDx fed fish all experienced a percent
increase in weight gain which were calculated to be 13.7%, 8%, and 27.8% respectively.
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Figure 20. Innate immune responses of rainbow trout 24 hours after being fed pellets containing
either polyI:C, polyI:C-NDx, or NDx a) IFN1 middle intestine b) Mx1 middle intestine c) Vig3
middle intestine d) IFN1 head kidney e) Mx1 head kidney f) Vig3 head kidney.
a)

d)

b)

c)

e)

Figure 21. Innate immune responses of rainbow trout 24 hours after a boost feeding of pellets
containing either polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine c)
Vig3 middle intestine d) Mx1 head kidney e) Vig3 head kidney. IFN1 levels were undetectable at
this timepoint in both groups in the head kidney.
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Figure 22. Innate immune responses of rainbow trout 24 hours after a second boost feeding of
pellets containing either polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine
c) Vig3 middle intestine d) Mx1 head kidney e) Vig3 head kidney. IFN1 levels were undetectable
at this timepoint in both groups in the head kidney.
a)
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d)
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Figure 23. Innate immune responses of rainbow trout 10 days after a second boost feeding of
pellets containing either polyI:C or polyI:C-NDx a) IFN1 middle intestine b) Mx1 middle intestine
c) Vig3 middle intestine d) Mx1 head kidney e) Vig3 head kidney.
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Figure 24. Average weight of rainbow trout at the start of the second feed pellet trial and at the
end for mock (water), polyI:C, polyI:C-NDx, and NDx fed fish.

3.4 Antiviral gene expression in middle intestine and head kidney of Atlantic salmon fed
polyI:C-NDx feed pellets
Atlantic salmon that were fed pellets containing either water or polyI:C-NDx were assessed
for their antiviral innate immune response by examining the expression of ISGs, IRF7, Mx1 and Vig3,
in the middle intestine and head kidney. Fish that had been fed polyI:C-NDx showed increased
expression levels of IRF7, Mx1 and Vig3 in the intestine 24 hours after receiving the feed, in
comparison to fish that were fed a mock without polyI:C-NDx (Figure 25. a, b, c). For example, 6 out
of 8 fish fed polyI:C-NDx had higher levels of expression of IRF7 and Mx1 compared to the group
average transcript levels of the fish that received a mock fed. IRF7, Mx1, and Vig3 were also
investigated 24 hours following the first treatment fed in the head kidney (Figure 25. d, e, f). At this
time point there was no observable difference in the expression of IRF7 systemically at this time point.
Consequently, Mx1 and Vig3 transcript levels in fish fed polyI:C-NDx show 7 out of 10 fish having
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higher levels of expression than the average transcript levels of fish fed a mock feed containing no
polyI:C-NDx.
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Figure 25. Innate immune responses of Atlantic salmon 24 hours after being fed pellets containing
either water (control) or polyI:C-NDx a) IRF7 middle intestine b) Mx1 middle intestine c) Vig3 middle
intestine d) IRF7 head kidney e) Mx1 head kidney f) Vig3 head kidney.

3.5 PolyI:C-NDx blended in feed pellet decreased viral load in Atlantic salmon middle
intestine
To determine if polyI:C-NDx could decrease the viral load of fish that were exposed to ISAV
through cohabitation infection, 18 days post infection middle intestine samples were assessed for
ISAV detection through quantitative probe-based qPCR. The copy number of ISAV detected in the
intestine of Atlantic salmon fed polyI:C-NDx was 7 times lower than that of the mock group (Figure
26). Although there was no statistical significance observed, overall, less viral RNA was detected in
the intestine of the polyI:C-NDx fed fish in comparison to fish that received no treatment feed which
positively correlates to the enhanced innate immune response that polyI:C-NDx feed induces.
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Mortality was also observed however it remained unchanged between the two groups. It was also
observed that the polyI:C-NDx treated group demonstrated more external hemorrhaging and
exophthalmia compared to the control group fed feed reformulated with water, with the control group
demonstrating more internal visceral hemorrhaging and congested livers.

Figure 26. Copy number of ISAV present in Atlantic salmon intestine samples that were fed
feed pellets reformulated with either water or polyI:C-NDx, detected through probe-based qPCR.
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Chapter 4. Discussion
Rainbow trout (Oncorhynchus mykiss) and Atlantic salmon (Salmo salar) are two
economically important teleost fish species, not only in Canada but globally. Canada for example
is the fourth largest producer of salmon in the world, trailing behind Norway, Chile, and Scotland
and therefore is an important part of our economy (Iversen et al., 2020). Many countries rely
heavily on these fish species to sustain their economy and population as a main source of food.
Each year there are still detrimental losses of farmed salmonid fish species due to pathogen
infections. As so many people rely on farmed trout and salmon it is extremely important that the
immune response of these salmonid species is well understood, to create new more effective
therapeutics to be able to overcome aquatic pathogens.
The present thesis describes the effects of an innate immune stimulant, polyI:C, delivered
in fish feed either alone or conjugated onto a phytoglycogen nanoparticle (polyI:C-NDx) in four
in vivo trials using salmonids. The first trial delivered the feed by oral gavage whereby moistened
feed in a 1ml syringe was delivered into the esophagus of the fish. This method was employed as
it ensures each fish receives the same dosage of the immunostimulant. It has also been suggested
that the GI tract is the most ideal route of antigen presentation and stimulation of innate immune
responses in fish due to the copious amounts of gut lymphoid tissue that is associated to the
intestinal mucosa (Rivas-Aravena et al., 2013). Additionally, the gut is also a preferred entry
method for many fish pathogens (Rivas-Aravena et al., 2013). Fish were collected 24 hours and
48 hours post first gavage and IFN1 and ISG transcript expression was measured in the midintestine and head kidney. The first conclusion that can be made is that the dsRNA supplemented
feed successfully reached the intestine. This can be concluded based on the innate immune
stimulation measured in the mid-intestine following treatment (Figure 10 a-c, Figure 11 a-c). The
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nanoparticle conjugated dsRNA induced a stronger response than dsRNA off the nanoparticle,
suggesting the nanoparticle may aid in not only receptor clustering, but also protection against
degradation in the stomach. A common issue with oral drugs is that antigens are degraded by the
gastric fish microenvironment where they are often digested before they are able to prime immune
cells (Somamoto and Nakanishi, 2020). This carrier molecule may be preventing degradation of
the polyI:C, by protecting it from the hostile environment of the stomach when delivered orally
(Mutoloki et al., 2015). The second conclusion that can be made is that the local innate immune
response was sufficient to induce a systemic response. This conclusion is based on the observation
that oral delivery of dsRNA-NDx was sufficient to induce IFN1 and ISGs in the head kidney 24h
and 48h post first oral gavage (Figure 10. d-f and Figure 11. d-f). Fish responded to the polyI:CNDx supplemented feed by expressing more IFN1 and ISG transcripts than polyI:C alone in the
mid-intestine. Although not always statistically significant, the trend was consistent across both
time points and all three genes. A third conclusion is that a second oral gavage may have a positive
impact on innate immune responses. It was able to induce statistically significantly more Vig3 in
the intestine compared to the first oral gavage treatment (Figure 10. c and 12. c), but the significant
increase in Vig3 in the head kidney after the first oral gavage was lost in the second (Figure 10. f
and 12. f). Finally the enhanced innate immune response induced by polyI:C-NDx extended to 7
days post second oral gavage. This suggests that the induced innate immune response can last over
1 week. Although there are no oral dsRNA studies involving the long-term effects of polyI:C on
the innate immune response, a study by Das et al. (2009) has previously shown that a salmonid
species, Atlantic salmon, can express Mx proteins up to 4 weeks following IP injection of polyI:C.
The data from the current study also suggests that polyI:C can induce long term innate immune
responses in rainbow trout up to 1 week following a boost feed, whereby the NPs are further
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enhancing these effects. The weights of the fish were also tracked to ensure that the fish were
continuing to show a healthy weight gain. Over the course of the trial the water group and poly I:C
group both experienced slight decreases in weight gain whereas the polyI:C-NDx group
experienced an increase in weight over the course of the trial. This decrease in weight for the water
and polyI:C group may be due to random sampling. For example, larger than the group average
fish may have been sampled at the earlier time points with the smaller ones being sampled at the
end attributing to the decrease whereas the polyI:C-NDX fish may have had more consistency in
random sampling.
This data suggests that NDx is a suitable carrier for the immunostimulant polyI:C as it
induced significantly stronger innate immune responses in comparison to polyI:C alone. When
evaluating the data, the reason why polyI:C-NDx is causing an upregulation of IFN and ISGs, may
be because of receptor clustering. DsRNA, such as polyI:C, is recognized by TLR3 to initiate
signaling pathways that leads to the production of type I IFNs and subsequently ISGs to increase
their antiviral defenses. A higher concentration of polyI:C on the surface of the PhG NPs may be
resulting in homo-clustering of TLR3 at the cells surface leading to stronger downstream signaling
of IFN and the ISGs Mx1 and Vig3, and therefore stronger antiviral innate immune responses
(Deci et al., 2017). The cationic PhG NPs used in this study may also be protecting the polyI:C
from degradation of the acidic stomach environment, whereby they are condensing the nucleic
acids on the surface, similar to that of cationic polyethylenimine (Pandey et al., 2016), where fish
fed polyI:C-NDx experience higher levels of expression of IFN and ISGs in comparison to polyI:C
alone. When polyI:C-NDx enters the GI tract there are two proposed mechanisms for entry and
innate immune stimulation locally and systemically (Figure 27). The first is that the complex is
being taken up by epithelial cells that line the intestine resulting in homo-clustering to increase
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stimulation of IFN1, which then travels through the blood to nearby hematopoietic tissues such as
the head kidney to then stimulate the production of more IFNs and ISGs to create a systemic
response. The second is that the complex is being taken up by microfold (M) cells located in the
gut which are transporting the antigens from the gut to immune cells in the head kidney and other
systemic organs to initiate transcription of IFNs and ISGs (Gerbet et al., 1996).

Figure 27. Proposed pathway of polyI:C-NDx uptake in the GI tract of teleost fish. Red bubble:
polyI:C-NDx is recognized by M cells which endocytose the complex and migrate to surrounding
tissue, where the complex is presented to stimulate the production of IFN and ISGs to initiate
systemic innate immune responses. Purple bubble: polyI:C-NDx is recognized by epithelial cells
where it is taken up and initiates the production of IFN. IFNs can then travel to surrounding tissue
to stimulate the production of more IFNs and ISGs to stimulate systemic innate immune responses.
Figure adapted from Mutoloki et al., 2015.
Once the antiviral innate immune responses of polyI:C when complexed with NDx were
elucidated through an oral gavage, the idea to incorporate them into feed pellets was tested. The
second oral delivery of an immunostimulant in rainbow trout animals was designed as a more
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feasible alternative to the oral gavage and to represent a more realistic approach of therapeutic
delivery for fish farmers (Somamoto and Nakanishi, 2020). By adding the immunostimulants into
feed pellets you eliminate the extra step of having to handle the fish to administer the therapeutic.
The trends observed in the oral gavage trial were similar in the feed pellet trial, whereby in almost
all cases the polyI:C-NDx supplemented feed produced a stronger innate immune response than
feed supplemented with polyI:C alone. Also similar to the oral gavage study, although the trend
was the same, transcript induction was higher locally in the intestine than systemically in the head
kidney. Indeed, both trials demonstrate that the immune response can remained elevated 7 days
post the last treatment, at least at the local level of the intestine (Figure 13 a-d, Figure 18, a-d). It
is interesting to note that 48h post the first feed there was no detectable IFN1, but 48h post the
second feed there was significantly more IFN1 in the poly I:C-NDx fed intestine compared to
polyI:C alone (Figure 16. a and b, Figure 17. a to c). This is further evidence that the second dose
of the polyI:C-NDx may be a beneficial therapeutic strategy. Comparing ISG transcript levels in
the intestine between trials, it is clear that although the oral gavage ensured equal delivery of the
polyI:C-NDx, it resulted in lower expression levels. For example, 48h post first oral gavage, Mx1
and Vig3 levels were averaging 3- and 5-fold increases respectively (Figure 11. b and c), while at
48h post first pellet feed Mx1 and Vig3 levels were averaging 25- and 36-fold change respectively
(Figure 16. a and b). The weights of the fish were also assessed for the first feed pellet trial which
showed an increase for all groups, with the polyI:C-NDx fed fish having the highest percent
increase of 30.2%. This indicates that the fish were able to maintain healthy increases in weight
which may correlate to healthy immune responses obtained from the treatment feedings as well as
the added benefit of not over handling the fish in comparison to the oral gavage trial.
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It is notable that on average more fish from the feed trial were considered higher responders
whereby more fish fed polyI:C-NDx expressed higher transcript levels of IFN1 and the ISGs
compared to the average of polyI:C alone, with higher expression levels in comparison to the oral
gavage trial. These results may be explained by side effects that are associated with oral gavage
trials in animals. This route of administration can result in esophageal and gastric injury or rupture
as well as induce stress of the fish (Turner et al., 2011). The added handling of fish can increase
their cortisol levels, a common marker of stress which positively correlates with a reduction in
immune responses (Braithwaite and Ebbesson et al., 2014). A study on the long-term effects of
stress on the epithelial immune response in Atlantic salmon has shown decreased levels of IFN-a1
and increased replication of IPNV in comparison to fish that experienced no stress (Gadan et al.,
2013). Differences between trials may also be attributed to the size of the fish. In the oral gavage
trial fish weighed on average 50g whereas fish in the first feed trial weighed on average 90g, where
the larger fish may have more mature immune systems making them more capable of mounting
stronger immune responses (Jensen et al., 2019) The differences in innate immune responses
between fish within the same treatment groups may be attributed to how rainbow trout may assert
dominance in environments where food or space is limited (Grobler and Wood et al., 2013). When
dominance is asserted smaller or weaker fish may not feed as much and therefore receive a smaller
dosage compared to the more dominant fish, explaining why some fish do not mount as strong of
an immune response after immunostimulation. The variation of responses between individuals of
the same group may also be attributed to the sex of the fish. It has been suggested that in fish
females have weaker immune responses and more disease susceptibility (Shepherd er al., 2012;
Dong et al., 2017). The fish used in these experiments were not sexually mature enough to sex
type, however with this knowledge the data may suggest that the males were able to elicit stronger
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innate immune responses in comparison to the females, therefore attributing to the variation within
a treatment group.
A second feed pellet trial was then conducted in rainbow trout, with the addition of a fourth
group, to test the effects of NDx alone on their innate immune responses. Feed pellets were
formulated the same way as the previous trial with the fourth group receiving 250μg of NDx. One
conclusion made by this study is that feed containing NDx alone did not induce innate immune
responses greater than the poly I:C alone group, thus the poly I:C needs to be conjugated onto the
nanoparticle to induce a more robust response. The second conclusion is that the trends replicated
between the two feed pellet studies, particularly 24h post first feed and post second feed (Figure
20. and Figure 21). Although not statistically significant, in these treatment groups the polyI:CNDx group induced a stronger response than the polyI:C or NDx alone. The rainbow trout’s
weights were again tracked in this trial to ensure a healthy increase in weight gain. The water group
experience a slight decrease in weight from the start to end of the trial which again may be
attributed to random sampling and not all fish weighing the exact same weight, with the larger fish
of the group being sampled first and the smaller at the end which could skew the results. The
remaining other groups all experienced an increase in weight from the start to the end of the trial.
There were however results from the second feed trial that were unique and did not match
the results from the earlier feed trials. For example, 24h post the second boost therapeutic feed the
polyI:C-NDx treated fish demonstrated lower IFN1 and ISG transcript levels compared to polyI:C
or NDx alone in the intestine (Figure 21. a-c). This trend was the same at 10 days post the second
therapeutic feed (Figure 23. a-c). These differences may be accounted for based on the health of
the fish. At the beginning of the experiment the trout had visible signs of a pathogenic infection.
Some fish were noted as having lesions, grey deflated eyes, red mouths, dark skin, and even
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internal white spots on the liver. The polyI:C-NDx feed may have acted as antiviral to prevent the
virus from further infection, whereas the polyI:C and NDx fed fish may have been fighting a
natural infection through the course of the trial accounting for their elevated innate immune
responses after the third and final treatment feed (Figure 22. a-c, Figure 23. a-c). The increased
innate immune responses of fish in the polyI:C and NDx group after the third and final treatment
may be a sum of the response of the immunostimulants as well at the response of a natural
infection, explaining the unexpected results at these timepoints. In an in vitro study using
RTgutGC cells, polyI:C-NDx was able to effectively limit VHSV-IVa replication in comparison
to polyI:C alone, which may be occurring in this study with an unknown pathogen (Alkie et al.,
2019). Another explanation is that the fish may have been over dosed and developed a tolerance
to the immunostimulants. For example, when fish are over stimulated with immunomodulating
compounds that fool the immune system into mounting a response, it can adversely affect the fish
by either skewing the developing immune system irreversibly to be primed for the stimuli or by
downregulating their response due to tolerance (Bricknell and Dalmo, 2005).
With the promising results of polyI:C when bound to NDx at enhancing antiviral innate
immune responses in rainbow trout, a pilot study was conducted to test the effects in another teleost
fish species, Atlantic salmon. The novel feed pellet in this study was not only tested for its ability
to induce immune responses but also for its ability to prevent viral replication of a globally
important viral fish pathogen ISAV. Atlantic salmon were divided into two groups, control and
polyI:C-NDx, with 4 tanks per group. Salmon were prophylactically treated with either
reformulated feed pellets containing water or polyI:C-NDx and then exposed to ISAV-infected
fish. Twenty-four hours following the first therapeutic treatment 5 fish were euthanized from two
of the control tanks and two of the treatment tanks to determine the effects of polyI:C when bound
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to NDx on the innate immune response. At this time point the treatment feed was able to induce
local innate immune responses whereby salmon fed polyI:C-NDx had higher levels of expression
of both IRF7, Mx1 and Vig3. The control group however did have expression of IRF7, Mx1, and
Vig3 which may be constitutively expressed at low levels as in humans (Jensen et al., 2002). At
24 hours the expression of IRF7, Mx1 and Vig3 was also observed in the head kidney, which again
showed that polyI:C-NDx was able to effectively increase innate immune transcript levels. This
data is consistent with previous studies using polyI:C in Atlantic salmon as an innate immune
stimulant of IFN and ISGs (Jensen et al., 2002; Andersen et al., 2020) however the addition of
NDx may be causing TLR3 homo-clustering to increase the response. This trial also tested the
ability for polyI:C-NDx feed to decrease viral replication in Atlantic salmon intestine. Twenty-one
days following a cohabitation infection of ISAV infected fish, the remaining fish were euthanized,
and portions of their intestine were collected for analysis using probe-based qPCR. At this time
point fish that were fed polyI:C-NDx had a lower copy number of ISAV on average detected in
the intestine than the control group that did not receive polyI:C-NDx, however no statistical
significance was observed. Although this study effectively limited viral replication of ISAV in the
mid-intestine there was no difference in mortality rates between the control and polyI:C-NDx
group. Interestingly however, through observation it was noted that fish fed polyI:C-NDx
experienced reduced internal pathologies in comparison to the control group. This may suggest
that the polyI:C-NDx is limiting virus located in the gut however virus entering through the skin
and or gills was not affected by the treatment resulting in no reduction in mortality rates. This pilot
study provides promising data that may be used in future studies to test the efficacy of polyI:CNDx on Atlantic salmon innate immune responses, which could lead to new therapeutics to fight
viral infections in the fish farming industry.
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These oral feed studies in rainbow trout and Atlantic salmon present a novel method of
innate immune stimulation in fish to benefit the fish farming industry. To date there are no studies
that employ the use of dsRNA incorporated into feed pellets to increase innate immune responses.
The feed created in these studies could be used as antiviral therapeutics in the aquaculture industry
to prevent viral or pathogenic outbreaks. Current methods in the fish farming industry include the
use of vaccines to prevent viral outbreaks. This feed could be used in unison with vaccines whereby
they are feed 24-48 hours before vaccination to help boost innate immune responses. They could
also be used in the salmon farming industry when fish are transferred to saltwater net pens. When
fish are transported, they have added exposure to pathogens or induce stress responses with
effectively weaken immune responses. If fed with this feed 24-48 hours before transportation, their
immune responses could be boosted to prevent pathogenic infections during movement. This novel
feed with the immunostimulants incorporated into it may provide a new method of antigen delivery
to boost innate immune responses with the goal of having overall healthier fish and less pathogenic
outbreaks.
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Chapter 5. Concluding Remarks
5.1 Conclusions
5.1.1. PolyI:C-NDx as an effective immunostimulant in rainbow trout and Atlantic
salmon
New therapeutics targeting the first line of defense in aquatic species, known as the innate
immune response, could hold the key to overcoming pathogenic infections in aquaculture. The
innate immune response consists of both physical and chemical barriers and inducible immune
responses (Collet, 2014). We can effectively activate these inducible innate immune responses
with the use of polyI:C, a synthetic dsRNA molecule. The effects of polyI:C on the innate immune
response have been well characterized in rainbow trout cells, with studies showing that polyI:C
can upregulate the expression of IFN1, Mx1 and Vig3 (Collet et al., 2003; DeWitte-Orr et al.,
2007; Poynter and DeWitte-Orr, 2015). However, the effects of polyI:C on the antiviral innate
immune responses at the whole animal level are not was well understood. Indeed, most trials with
dsRNA in vivo used an injection method for delivery. The intent of this study was to focus on
using feed-delivered dsRNA to stimulate innate immune responses in the gut of fish. For this
reason, it was used with the phytoglycogen nanoparticle, NDx, to help strengthen its response at
the whole animal level.
This is the first study to characterize polyI:C-NDx when delivered orally and was effective
as both using oral gavage and when incorporated into feed pellets at stimulating the production of
IFN, Mx1 and Vig3 both locally and systemically in rainbow trout. This novel feed was also able
to stimulate higher levels of expression IRF7, Mx1, and Vig3 in Atlantic salmon locally in the
intestine when compared to control fish. The results from these studies could advance the
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development of therapeutics in the aquaculture industry with the goal of having overall healthier
fish.
5.1.2 Future directions
Future directions of this work may include a water bath of polyI:C-NDx opposed to feed
pellets. This may be a particularly important strategy to prevent viral infection for viruses that
enter via skin and gills, such as ISAV (Aamelfot et al., 2015). This method could be tested in both
rainbow trout and Atlantic salmon to determine if it is a viable method for multiple economically
important farmed fish species. Currently there are no published trials that employ an immersion
bath of polyI:C in rainbow trout or Atlantic salmon to boost innate immune responses as a method
to overcome viral infections. The same dosage used in the oral trials would be employed as it
effectively stimulates innate immune response in both trout and salmon. An immersion bath study
with polyI:C-NDx may provide more homogenous data, whereby it would eliminate any
dominance between fish fed pellets as all fish would receive an equal dosage as they are immersed
in the immunostimulant. This method of immune stimulation would benefit fish farmers greatly
as it is inexpensive and requires little labour, in comparison to injection methods (Dhar et al.,
2014). This method of innate immune stimulation may be extremely beneficial for Atlantic salmon
farmers specifically, due to the excess handling of the fish when having to move them to saltwater
net pens, whereby the fish could be immersed in the polyI:C-NDx to boost innate immune
responses before transportation to help protect against any pathogenic threats. Through this
method, polyI:C-NDx may be able to better protect the fish externally to prevent viral pathogens
from overcoming their physical barriers.
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5.2 How this work is integrative
An integrative approach is imperative to a successful research project. Integrative biology
by definition uses a diverse variety of biological disciplines to understand the nature of the subject.
Previous studies used the novel PhG NPs at the cellular level, the smallest form of life, to study its
effects as an immunostimulant as well as its cytotoxicity. I employed this NP to study its effects
as an immunostimulant and antiviral treatment at the whole animal level, merging in vitro and in
vivo effects. This research also spanned across two teleost fish species to compare its effects. Two
disciplines of biology, immunology, and virology, where merged together to determine the
efficacy of polyI:C-NDx as an immunostimulant and therapeutic in the aquaculture sector. This
study was also integrative as it bridged a gap between the molecular biology and biophysics world,
as these NPs were developed by biophysicists allowing their creation to be applied in a real-world
setting. These integrative approaches to the study may help alleviate future pathogenic infections
for fish farmers globally.
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